Close Menu

A Range of Risk

Personalized genetic tests may be flawed and have few health benefits, reports Ian Sample at the Guardian. Researchers from Erasmus University Medical Center in Rotterdam, the Netherlands, simulated genetic data from 100,000 people and then used 23andMe and DecodeMe's formulas to predict the risk of eight health conditions for that simulated population.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Kaiser Health News reports San Francisco and Alameda counties in California are no longer using Verily Life Sciences' COVID-19 testing program.

The New York Times reports that developers in New York City are increasingly interested in life science spaces.

A UK study has found that antibodies against SARS-CoV-2 may decline over time, Reuters reports.

In PNAS this week: genetic and epigenetic variation in individuals with diabetic kidney disease, spontaneous genetic alterations in Saccharomyces cerevisiae, and more.